A. Amann et al., The influence of atracurium, cisatracurium, and mivacurium on the proliferation of two human cell lines in vitro, ANESTH ANAL, 93(3), 2001, pp. 690-696
Citations number
20
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
We tested the influence of atracurium and cisatracurium (final concentratio
ns: 0, 0.96, 3.2, 9.6, 32, and 96 muM) on proliferation of human cells (hep
atoma HepG2 cells and human umbilical vein endothelial cells) in vitro. In
additional experiments, glutathione, N-acetylcysteine, or carboxyl esterase
was added before the addition of either relaxant. The number of cells, cou
nted after 72 h of incubation was expressed as a percentage of the mean cel
l number in wells incubated without additives. Atracurium and cisatracurium
progressively decreased cell proliferation in a concentration-dependent pa
ttern. With human umbilical vein endothelial cells, atracurium or cisatracu
rium (3.2 muM) decreased the cell count to 67.7 % (SD, 14.8%) and 50% (SD,
8.6%), respectively. Cell proliferation was not inhibited by mivacurium. Th
e results were similar to those with HepG2 cells. Glutathione, N-acetylcyst
eine, and carboxyl esterase partially reversed the effects of atracurium an
d cisatracurium. When incubated in a buffer with glutathione, atracurium de
creased the number of glutathione-sulfhydryl groups. The findings that atra
curium and cisatracurium inhibit proliferation of human cell lines in vitro
, but that mivacurium does not, and that this effect is alleviated by gluta
thione and N-acetylcysteine, as well as by the carboxyl esterase, indicate
that the inhibition may be caused by the reactive acrylate metabolites.